News | August 26, 2014

Vision RT Brings Its Innovative Optical Guidance Technology to Japan

Vision RT Optical Guidance AlignRT Japan Radiation Therapy Patient Positioning

August 26, 2014 — Vision RT launched its motion management solutions in the Japanese market, after receiving clearance from the PMDA.

Following great success in other regions, most notably in the United States, Vision RT is now collaborating with Accuthera, a leading radiation therapy manufacturer based in Japan. With Accuthera, Vision RT can ensure that the AlignRT system reaches many medical centers in the world’s second largest advanced radiation therapy market.

Eiji Tanabe, president and CEO of Accuthera, said, “We’re enthusiastic about bringing Vision RT’s cutting-edge solutions to the Japanese market. These products increase accuracy and enhance safety during radiation delivery; this is crucial for the advancements of radiation therapy in Japan.”

The Makuhari Clinic in Chiba was the first Japanese center to adopt the AlignRT system. It was installed in this February, and the clinic intends to use it when treating all radiation therapy patients on all treatment sites.

Dr. Kazuo Hatano, director of the Makuhari Clinic, said, “We have chosen the AlignRT motion management system to help ensure that our radiation therapy patients receive safe, swift and accurate treatment. Our patients tell us that the system is more comfortable as it does not require restrictive immobilization.”

With Accuthera, Vision RT intends to reach more centers across Japan and has arranged a presentation on treatment techniques for Japanese customers to take place at the ASTRO 56th Annual Meeting. The presentation will highlight the benefits of using AlignRT for high precision treatment techniques.

Accuthera will also present Vision RT to Japanese customers at this year’s JASTRO conference on Dec. 11-13 in Pacifico Yokohama.

For more information: www.visionrt.com

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve